2 weeks Ago By ABMN Staff
HB Wealth Management LLC increased its position in shares of Laboratory Co. of America Holdings ( NYSE:LH – Free Report ) by 5.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC.
The firm owned 2,357 shares of the medical research company’s stock after buying an additional 124 shares during the quarter. HB Wealth Management LLC’s holdings in Laboratory Co. of America were worth $480,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in LH. Norges Bank acquired a new position in Laboratory Co. of America in the fourth quarter valued at about $291,045,000.
Bank of New York Mellon Corp increased its position in shares of Laboratory Co. of America by 135.0% in the 2nd quarter.
Bank of New York Mellon Corp now owns 1,609,826 shares of the medical research company’s stock valued at $327,616,000 after purchasing an additional 924,881 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in shares of Laboratory Co. of America by 58.
8% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,613,854 shares of the medical research company’s stock valued at $352,563,000 after purchasing an additional 597,571 shares in the last quarter. Veritas Investment Partners UK Ltd.
lifted its position in shares of Laboratory Co. of America by 32.5% during the 4th quarter.
Veritas Investment Partners UK Ltd. now owns 1,140,300 shares of the medical research company’s stock worth $259,133,000 after purchasing an additional 279,628 shares during the last quarter. Finally, Public Sector Pension Investment Board grew its stake in shares of Laboratory Co.
of America by 2,750.2% during the fourth quarter. Public Sector Pension Investment Board now owns 270,483 shares of the medical research company’s stock worth $61,478,000 after purchasing an additional 260,993 shares in the last quarter.
95.94% of the stock is currently owned by institutional investors and hedge funds. Laboratory Co.
of America Stock Down 0.5 % Shares of Laboratory Co. of America stock opened at $229.
65 on Friday. Laboratory Co. of America Holdings has a one year low of $191.
97 and a one year high of $238.46. The company has a market cap of $19.
36 billion, a P/E ratio of 46.21, a PEG ratio of 1.76 and a beta of 1.
05. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.
76 and a current ratio of 0.88. The firm has a fifty day moving average of $215.
57 and a two-hundred day moving average of $210.76. Laboratory Co.
of America Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Thursday, August 29th will be issued a $0.72 dividend.
This represents a $2.88 dividend on an annualized basis and a yield of 1.25%.
The ex-dividend date is Thursday, August 29th. Laboratory Co. of America’s dividend payout ratio (DPR) is currently 57.
95%. Analyst Upgrades and Downgrades A number of brokerages have issued reports on LH. StockNews.
com raised Laboratory Co. of America from a “hold” rating to a “buy” rating in a report on Tuesday, August 20th. UBS Group boosted their target price on Laboratory Co.
of America from $260.00 to $270.00 and gave the stock a “buy” rating in a research note on Friday, August 2nd.
Robert W. Baird raised their price objective on shares of Laboratory Co. of America from $261.
00 to $277.00 and gave the stock an “outperform” rating in a report on Friday, August 2nd. Deutsche Bank Aktiengesellschaft upped their target price on shares of Laboratory Co.
of America from $220.00 to $230.00 and gave the company a “hold” rating in a report on Friday, August 2nd.
Finally, Truist Financial upped their price objective on shares of Laboratory Co. of America from $255.00 to $275.
00 and gave the company a “buy” rating in a research note on Friday, August 2nd. Four equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat.
com, the stock has an average rating of “Moderate Buy” and an average target price of $247.42. Check Out Our Latest Analysis on Laboratory Co.
of America Insiders Place Their Bets In related news, EVP Lance Berberian sold 12,093 shares of the business’s stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $229.10, for a total transaction of $2,770,506.
30. Following the sale, the executive vice president now owns 15,921 shares of the company’s stock, valued at $3,647,501.10.
The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link . In other news, Director Kerrii B. Anderson sold 586 shares of the firm’s stock in a transaction on Thursday, August 8th.
The stock was sold at an average price of $225.00, for a total value of $131,850.00.
Following the completion of the transaction, the director now owns 14,722 shares in the company, valued at $3,312,450. The sale was disclosed in a document filed with the SEC, which is available at this link . Also, EVP Lance Berberian sold 12,093 shares of the business’s stock in a transaction dated Monday, August 5th.
The stock was sold at an average price of $229.10, for a total transaction of $2,770,506.30.
Following the completion of the sale, the executive vice president now owns 15,921 shares in the company, valued at $3,647,501.10. The disclosure for this sale can be found here .
In the last ninety days, insiders have sold 29,679 shares of company stock worth $6,716,306. Corporate insiders own 0.85% of the company’s stock.
About Laboratory Co. of America ( Free Report ) Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS).
Featured Articles Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Co. of America Holdings ( NYSE:LH – Free Report ).
Receive News & Ratings for Laboratory Co. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Co. of America and related companies with MarketBeat.
com's FREE daily email newsletter ..
